ASCO 2016 Update: Checkpoint Immunotherapy Advances in Solid Cancers June 6, 2016December 14, 2022 Arthur N. Brodsky, PhD
FDA Approves Nivolumab (Opdivo) for Advanced Hodgkin Lymphoma Patients May 17, 2016December 14, 2022 Arthur N. Brodsky, PhD
#AACR16 Update: Checkpoint Inhibition and Improving Anti-Tumor Immunity April 17, 2016December 14, 2022 Arthur N. Brodsky, PhD
Oncogene Initiates Cancer Development through Immune Checkpoints March 10, 2016December 14, 2022 Alexandra Mulvey
Former President Jimmy Carter Declared Cancer-Free, Thanks to Immunotherapy December 7, 2015August 28, 2023 Arthur N. Brodsky, PhD